Sarah Cannon Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.
Sarah Cannon Cancer Center has participated in 69 clinical trials with 12 currently active.
Therapeutic areas: Advanced Cancer, Metastatic Melanoma, Metastatic Non-small Cell Lung Cancer.
Sponsors: Eli Lilly and Company, Achieve Life Sciences, Infinity Pharmaceuticals, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Cancer Center has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Cancer Center has 69 clinical trials on record, with 12 currently active. Their work covers Advanced Cancer, Metastatic Melanoma, Metastatic Non-small Cell Lung Cancer.
Sarah Cannon Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.